National-level activities are needed to drive implementation of the Survivorship Passport across Europe. In April 2022 and September 2022, CCRI‘s Prof. Ruth Ladenstein and Vanessa Duester presented ‘Status update and next steps for SurPass implementation in Austria’ to around 70 participants of the Arbeitsgemeinschaft für pädiatrische Hämatologie und Onkologie (AGPHO) Working Group for Paediatric Haematology and Oncology in Austria. Besides the national coordination and conduct of clinical trials, the group is involved in cooperations with international consortia and European activities, such as the implementation of the Survivorship Passport.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899999. The material presented and views expressed here are the responsibilities of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.